Two proteins of particular interest were serum amyloid A2 (SAA2) and serum amyloid P component (Apcs or SAP), as these have been implicated in AD[50, 51, 52] and aging, and the aging‐associated increase in their levels was significantly decreased in the plasma of iMP‐treated mice (Figure 5C). This evidence concerns the gene APCS and Alzheimer disease.